Research

Study finds increased breast cancer risk

A new study published by Dovepress suggests women with neurofibromatosis type 1 begin screening for breast cancer at age 30 due to increased risk between ages 30 and 50.

New cell of origin for optic gliomas identified

A new study revealed information about the development of optic gliomas, a type of tumor children with NF1 are susceptible to.

Genetic tests + coordinated care + research = HOPE

Life with an inherited disease sometimes brings unexpected twists and turns. Five-year-old Gus Erickson has navigated the gyrations with the help of Mayo Clinic’s Neurofibromatosis Clinic.

New research offers hope to neuro-tumor patients

New research could offer hope to the thousands of people affected by Neurofibromatosis 2.

Participate in NF research

Did you know that there are 167 clinical trials for neurofibromatosis (NF) in various stages of completion? People with NF can play a critical role in the development of new treatments and the search for a cure by participating in clinical trials.

Washington U professor receives $3.5M grant

David H. Gutmann, director of the Neurofibromatosis Center at the Washing University School of Medicine in St. Louis, was awarded a $3.5 million grant to study NF1.

Drug shrinks pediatric neural tumors

In an early-phase clinical trial, in most cases, children with neurofibromatosis type 1 and plexiform neurofibromas responded with tumor shrinkage.

Swedish teen walks using 3D printed hip implant

Fanny Fellesen, a Swedish 16-year-old with neurofibromatosis, was told she would never walk again.

Drug shows promise with hearing loss

A drug already in use for some cancers is not only halting hearing loss in some patients, but reversing it.

New drug approved for NF2 treatment

BioXcel announced the U.S. Food and Drug Administration has granted Orphan Drug Designation to BXCL101 for the treatment of Neurofibromatosis Type 2.


Want to view archived newsletters? Click Here!

Newsletter

Sign up to receive the latest neurofibromatosis news and information in your inbox!

Subscribe

Categories

Have a story you'd like to share with the NF community? Click Here!